Inhibition of GSK-3 Ameliorates Aβ Pathology in an Adult-Onset Drosophila Model of Alzheimer's Disease
暂无分享,去创建一个
Linda Partridge | Simon Lovestone | Iain Rogers | M. J. Allen | L. Partridge | S. Lovestone | C. Gandy | J. Hardy | Richard Killick | R. Killick | John Hardy | F. Kerr | Oyinkan Sofola | I. Rogers | H. Augustin | Fiona Kerr | Oyinkan Sofola | Hrvoje Augustin | Carina Gandy | Marcus J. Allen | M. Allen | J. Hardy
[1] R. Hen,et al. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. , 2001, The EMBO journal.
[2] T. Saido,et al. Metabolic regulation of brain Abeta by neprilysin. , 2001, Science.
[3] L. Marlow,et al. Alzheimer's Disease β-Amyloid Peptide Is Increased in Mice Deficient in Endothelin-converting Enzyme* , 2003, The Journal of Biological Chemistry.
[4] Christina A. Wilson,et al. GSK-3α regulates production of Alzheimer's disease amyloid-β peptides , 2003, Nature.
[5] F. van Leuven,et al. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. , 2008, The American journal of pathology.
[6] W. Bender,et al. A Drosophila model of Parkinson's disease , 2000, Nature.
[7] B. Lu,et al. PAR-1 Kinase Plays an Initiator Role in a Temporally Ordered Phosphorylation Process that Confers Tau Toxicity in Drosophila , 2004, Cell.
[8] J. Shulman,et al. The role of PAR-1 in regulating the polarised microtubule cytoskeleton in the Drosophila follicular epithelium , 2003, Development.
[9] D. Selkoe,et al. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. , 2003, Annual review of pharmacology and toxicology.
[10] F. LaFerla,et al. Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. , 2007, The American journal of pathology.
[11] Christina A. Wilson,et al. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. , 2003, Nature.
[12] Stephan J. Froggett,et al. Targeted Expression of Truncated Glued Disrupts Giant Fiber Synapse Formation in Drosophila , 1999, The Journal of Neuroscience.
[13] D. Shepherd,et al. Aβ exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease , 2010, Experimental Neurology.
[14] V. Pantesco,et al. Drosophila shaggy kinase and rat glycogen synthase kinase-3 have conserved activities and act downstream of Notch , 1993, Nature.
[15] Jason Eriksen,et al. A decade of modeling Alzheimer's disease in transgenic mice. , 2006, Trends in genetics : TIG.
[16] J. Ávila,et al. Characterization of a double (amyloid precursor protein-tau) transgenic: Tau phosphorylation and aggregation , 2005, Neuroscience.
[17] M. Mercken,et al. Presenilin Redistribution Associated with Aberrant Cholesterol Transport Enhances β-Amyloid Production In Vivo , 2003, The Journal of Neuroscience.
[18] Huaxi Xu,et al. Effects of endogenous β‐amyloid overproduction on tau phosphorylation in cell culture , 2006, Journal of neurochemistry.
[19] R. Nitsch,et al. Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.
[20] A. Harwood,et al. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. , 2001, Biochemical and biophysical research communications.
[21] Joshua M. Shulman,et al. Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles , 2001, Science.
[22] Kanae Iijima-Ando,et al. Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease. , 2010, Human molecular genetics.
[23] Simon Lovestone,et al. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells , 1994, Current Biology.
[24] W. Noble,et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[25] M. J. Allen,et al. Making an escape: development and function of the Drosophila giant fibre system. , 2006, Seminars in cell & developmental biology.
[26] S. Lovestone,et al. GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila , 2004, Molecular Psychiatry.
[27] A. Bejsovec,et al. Cellular mechanisms of wingless/Wnt signal transduction. , 1999, Current topics in developmental biology.
[28] René Hen,et al. Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice , 2001 .
[29] L. Pennanen,et al. Different tau epitopes define Aβ42-mediated tau insolubility , 2005 .
[30] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[31] T. Aigaki,et al. Insulin‐degrading enzyme antagonizes insulin‐dependent tissue growth and Aβ‐induced neurotoxicity in Drosophila , 2010, FEBS letters.
[32] T. Dale,et al. Glycogen synthase kinase 3: A key regulator of cellular fate , 2007, Cellular and Molecular Life Sciences.
[33] Benjamin H. White,et al. A conditional tissue-specific transgene expression system using inducible GAL4 , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] C. Duijn,et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. , 1999, American journal of human genetics.
[35] D. Selkoe,et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. Götz,et al. Different tau epitopes define Abeta42-mediated tau insolubility. , 2005, Biochemical and Biophysical Research Communications - BBRC.
[37] J. Woodgett,et al. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase , 1992, Neuroscience Letters.
[38] K. Irvine,et al. In vivo regulation of Yorkie phosphorylation and localization , 2008, Development.
[39] D. Chuang,et al. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[40] S Lovestone,et al. GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila , 2004, Molecular Psychiatry.
[41] R. Wyman,et al. Motor outputs of giant nerve fiber in Drosophila. , 1980, Journal of neurophysiology.
[42] M. Bianchi,et al. Functional Studies of Shaggy/Glycogen Synthase Kinase 3 Phosphorylation Sites in Drosophila melanogaster , 2004, Molecular and Cellular Biology.
[43] B. Hyman,et al. Transgenic models of Alzheimer’s disease: Learning from animals , 2005, NeuroRX.
[44] L. Mucke,et al. Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.
[45] K. White,et al. A Drosophila gene encoding a protein resembling the human beta-amyloid protein precursor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[46] G. Drewes,et al. Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tau , 1992, FEBS letters.
[47] J. Hardy,et al. Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.
[48] A. Joutel,et al. Notch signalling pathway and human diseases. , 1998, Seminars in cell & developmental biology.
[49] E. Kinoshita,et al. Phosphate-binding Tag, a New Tool to Visualize Phosphorylated Proteins*S , 2006, Molecular & Cellular Proteomics.
[50] G. Drewes,et al. MARK, a Novel Family of Protein Kinases That Phosphorylate Microtubule-Associated Proteins and Trigger Microtubule Disruption , 1997, Cell.
[51] Ann-Shyn Chiang,et al. Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila: A potential model for Alzheimer's disease , 2004 .
[52] F. van Leuven,et al. Glycogen synthase kinase‐3β, or a link between amyloid and tau pathology? , 2008, Genes, brain, and behavior.
[53] P. Lochhead,et al. A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation. , 2006, Molecular cell.
[54] Ronald L. Davis,et al. Spatiotemporal Gene Expression Targeting with the TARGET and Gene-Switch Systems in Drosophila , 2004, Science's STKE.
[55] S. Younkin,et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation , 2001, Nature Neuroscience.
[56] D. Gubb,et al. Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. , 2005, Neuroscience.
[57] Ehud Cohen,et al. Opposing Activities Protect Against Age-Onset Proteotoxicity , 2006, Science.
[58] David H. Cribbs,et al. Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome , 2004, Neuron.
[59] J. Melchor,et al. The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. , 2003, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[60] N. Mivechi,et al. Glycogen Synthase Kinase 3β and Extracellular Signal-Regulated Kinase Inactivate Heat Shock Transcription Factor 1 by Facilitating the Disappearance of Transcriptionally Active Granules after Heat Shock , 1998, Molecular and Cellular Biology.
[61] T. Saido,et al. Metabolic Regulation of Brain Aβ by Neprilysin , 2001, Science.
[62] F. LaFerla,et al. Genetically augmenting tau levels does not modulate the onset or progression of Aβ pathology in transgenic mice , 2007, Journal of neurochemistry.
[63] M. Konsolaki,et al. A model for studying Alzheimer's Aβ42-induced toxicity in Drosophila melanogaster , 2004, Molecular and Cellular Neuroscience.
[64] S. Lovestone,et al. Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice , 2009, Biochemical and biophysical research communications.
[65] K. Walsh,et al. Intraneuronal β-Amyloid Expression Downregulates the Akt Survival Pathway and Blunts the Stress Response , 2005, The Journal of Neuroscience.
[66] I. Hakker,et al. Overexpression of Neprilysin Reduces Alzheimer Amyloid-β42 (Aβ42)-induced Neuron Loss and Intraneuronal Aβ42 Deposits but Causes a Reduction in cAMP-responsive Element-binding Protein-mediated Transcription, Age-dependent Axon Pathology, and Premature Death in Drosophila* , 2008, Journal of Biological Chemistry.
[67] J. Lucas,et al. Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits , 2010, Neurobiology of Disease.
[68] Ann-Shyn Chiang,et al. Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[69] Matthew P. Frosch,et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[70] Richard M. Page,et al. Intraneuronal Aβ, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer’s disease , 2005, Neuroscience.
[71] J. C. Hall,et al. Identification of a cholinergic synapse in the giant fiber pathway of Drosophila using conditional mutations of acetylcholine synthesis. , 1984, Journal of neurogenetics.
[72] E. Masliah,et al. Neuroprotective Effects of Regulators of the Glycogen Synthase Kinase-3β Signaling Pathway in a Transgenic Model of Alzheimer's Disease Are Associated with Reduced Amyloid Precursor Protein Phosphorylation , 2007, The Journal of Neuroscience.
[73] J. Melchor,et al. The Tissue Plasminogen Activator-Plasminogen Proteolytic Cascade Accelerates Amyloid-β (Aβ) Degradation and Inhibits Aβ-Induced Neurodegeneration , 2003, The Journal of Neuroscience.
[74] W. Noble,et al. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. , 2009, Trends in molecular medicine.
[75] D. Selkoe,et al. Enhanced Proteolysis of β-Amyloid in APP Transgenic Mice Prevents Plaque Formation, Secondary Pathology, and Premature Death , 2003, Neuron.
[76] Colin L Masters,et al. Aβ aggregation and possible implications in Alzheimer's disease pathogenesis , 2009, Journal of cellular and molecular medicine.
[77] C. Strambi,et al. Decreasing Glutamate Buffering Capacity Triggers Oxidative Stress and Neuropil Degeneration in the Drosophila Brain , 2004, Current Biology.
[78] M. Ruberg,et al. A Conditional Pan-Neuronal Drosophila Model of Spinocerebellar Ataxia 7 with a Reversible Adult Phenotype Suitable for Identifying Modifier Genes , 2007, The Journal of Neuroscience.
[79] D. Geschwind,et al. Human Wild-Type Tau Interacts with wingless Pathway Components and Produces Neurofibrillary Pathology in Drosophila , 2002, Neuron.
[80] Patrick R Hof,et al. Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[81] M. Bourouis. Targeted increase in shaggy activity levels blocks wingless signaling , 2002, Genesis.
[82] L. Hersh,et al. Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[83] F. Liu,et al. Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing. , 2004, Biochemistry.
[84] Kit-Yi Leung,et al. Novel Phosphorylation Sites in Tau from Alzheimer Brain Support a Role for Casein Kinase 1 in Disease Pathogenesis* , 2007, Journal of Biological Chemistry.
[85] Barry Ganetzky,et al. On the relationship between senescence and age-related changes in two wild-type strains of Drosophila melanogaster , 1978, Experimental Gerontology.
[86] D. Nanopoulos,et al. Learning and memory deficits upon TAU accumulation in Drosophila mushroom body neurons. , 2004, Learning & memory.
[87] Damian C Crowther,et al. A Drosophila model of Alzheimer's disease. , 2006, Methods in enzymology.
[88] U. Wagner,et al. Tau phosphorylation in transgenic mice expressing glycogen synthase kinase‐3β transgenes , 1997, Neuroreport.
[89] D. Shepherd,et al. A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies , 2007, Invertebrate Neuroscience.